Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Kraft Heinz Co — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while Kraft Heinz Co trades at $22.99 (market cap $26.60B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Kraft Heinz Co pays the higher dividend (7.13%). Which is the better fit depends on your goals.
| GEHC | KHC | |
|---|---|---|
Market Cap | $31.07B | $26.60B |
Volume | 3,443,020 | 11,136,448 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $27.62 |
52-Week Low | $59.48 | $21.21 |
Enterprise Value | $39.53B | $42.92B |
Dividend Yield | 0.23% | 7.13% |
Typical Hold Time | — | 129 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Kraft Heinz (KHC) trades at $22.43, down 0.09% with bearish technical signals despite recent earnings beats. The company faces fundamental challenges with a net loss of $5.85 billion in 2025 and negative profit margins, though operating cash flow remains strong at $4.46 billion. Recent news highlights ongoing turnaround efforts including new product launches and a $700 million reinvestment strategy to revive brands.
The stock presents a mixed outlook with attractive valuation metrics (P/E 13.04, P/B 0.74) and 6.5% dividend yield, but significant execution risks persist. Analyst consensus leans cautious with 57% hold ratings, while institutional interest remains with recent large purchases. Key risks include continued volume declines, high debt load, and competitive pressures in the consumer goods sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
